Understanding the mix-up
If you have inflammatory bowel disease (IBD), you have probably heard someone confuse it with irritable bowel syndrome (IBS). The two conditions share similar abbreviations, both affect the gut, and they can cause overlapping symptoms like abdominal pain, bloating, and changes in bowel habits. But they are fundamentally different. One involves ongoing inflammation and damage to the gut lining, whilst the other does not. Understanding the difference matters, because the treatments, long-term outlook, and medical support are not the same.
What is IBD?
Inflammatory bowel disease is a group of conditions that cause long-term inflammation in the gut. The two main types are Crohn’s disease and ulcerative colitis. In Crohn’s disease, inflammation can occur anywhere along the digestive tract, often affecting deeper layers of tissue. In ulcerative colitis, inflammation is limited to the colon and rectum, affecting the innermost lining.
IBD is classed as an autoimmune condition, meaning the immune system mistakenly attacks the gut lining, leading to visible inflammation, ulcers, and sometimes scarring or narrowing of the bowel. Symptoms include diarrhoea, blood in the stool, weight loss, fatigue, and abdominal pain, with periods of flare and remission.
What is IBS?
Irritable bowel syndrome is a functional gut disorder. This means it affects how the gut works, but does not cause visible inflammation or lasting damage to the gut lining. People with IBS experience abdominal pain, cramping, bloating, diarrhoea, constipation, or both. The symptoms can be uncomfortable and persistent, but there is no injury to the gut tissue.
The exact cause of IBS is not fully understood. It is thought to involve changes in gut motility, sensitivity to stretching or discomfort, and how the brain and gut communicate. Stress, diet, and changes in gut bacteria may also play a role.
Why the confusion happens
The most obvious reason for confusion is the similarity in abbreviations. IBD and IBS sound alike and are often mentioned together in online searches or conversations about digestive health. Both conditions can cause abdominal pain, bloating, and changes in bowel habits, so people often assume they are the same thing.
Many people, including some healthcare professionals who are not gastroenterology specialists, may not be familiar with the differences. This can lead to misunderstandings when someone tries to explain their condition to friends, family, or colleagues.
How they differ in what is happening inside the body
The key difference is inflammation. In IBD, there is active inflammation in the gut that can be seen during a colonoscopy or on imaging scans. This inflammation can lead to ulcers, bleeding, and long-term complications if not managed appropriately. Blood tests may show markers of inflammation, such as raised C-reactive protein (CRP) or faecal calprotectin.
In IBS, these tests are typically normal. There is no visible inflammation, and the gut lining looks healthy under examination. The symptoms arise from changes in gut function, not from immune activity or tissue damage.
How they differ in diagnosis
Diagnosing IBD usually involves tests such as colonoscopy, imaging scans, stool tests, and blood tests to see inflammation and rule out other causes. A biopsy of the gut lining may also be taken during a colonoscopy to confirm the diagnosis.
IBS is diagnosed based on symptoms and by ruling out other conditions. There is no single test that confirms IBS. Doctors may carry out blood tests, stool tests, or scans to ensure there is no inflammation, infection, or other underlying problem. Once other causes are excluded, a diagnosis of IBS may be made.
How they differ in treatment
Treatment for IBD focuses on reducing inflammation, healing the gut lining, and preventing flares. This may involve medicines such as aminosalicylates (ASAs), corticosteroids, immunosuppressants, or biologic therapies. In some cases, surgery may be needed. The goal is to control the immune response and protect the gut from long-term damage.
Treatment for IBS focuses on managing symptoms through dietary changes, stress management, medicines to help with pain or bowel movements, and sometimes psychological support such as cognitive behavioural therapy. There is no need for immunosuppressive treatment, because there is no inflammation to control.
Why it matters to get it right
Misunderstanding the difference can lead to delays in diagnosis, incorrect treatment, or unnecessary worry. Someone with IBD needs close monitoring and medical treatment to reduce inflammation and prevent complications. Someone with IBS may not need the same level of investigation or treatment, but still deserves proper support to manage their symptoms.
It is also important emotionally. Living with IBD means managing a long-term condition that requires ongoing medical care. Being told ‘it is just IBS’ can feel dismissive, particularly if symptoms are severe or affecting daily life. Conversely, someone with IBS should not be made to feel their symptoms are not real or worth attention simply because there is no visible inflammation.
Practical takeaways
- If you are experiencing persistent gut symptoms, speak to your GP and ask for appropriate tests to rule out inflammation or other underlying conditions.
- Keep a record of your symptoms, including when they happen, what makes them better or worse, and any other changes such as weight loss, blood in the stool, or fatigue.
- If you have been diagnosed with IBS but your symptoms change or worsen, ask for a review.
- If you have IBD, it can be helpful to explain to others that it is not the same as IBS and involves ongoing inflammation that needs medical treatment.
- Both conditions can affect quality of life, and both deserve proper support and management tailored to the individual.
Conclusion
IBD and IBS may sound similar, but they are distinct conditions with different causes, treatments, and outlooks. IBD involves ongoing inflammation and immune activity that can damage the gut, whilst IBS affects how the gut functions without causing visible harm. Getting the right diagnosis matters, because it ensures the right support and treatment. If you are unsure about your diagnosis or symptoms, speak to your healthcare team for clarity and guidance.
References
- Dolinger M, Torres J, Vermeire S. Crohn’s disease. Lancet. 2024;403(10432):1177-1191. doi:10.1016/S0140-6736(23)02586-2
- Le Berre C, Honap S, Peyrin-Biroulet L. Ulcerative colitis. Lancet. 2023;402(10401):571-584. doi:10.1016/S0140-6736(23)00966-2
- Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393-1407. doi:10.1053/j.gastro.2016.02.031
- Spiller R, Aziz Q, Creed F, et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut. 2007;56(12):1770-1798. doi:10.1136/gut.2007.119446
- Feuerstein JD, Isaacs KL, Schneider Y, et al. AGA clinical practice guidelines on the role of biomarkers for the management of ulcerative colitis. Gastroenterology. 2023;164(3):344-372. doi:10.1053/j.gastro.2022.12.007
- Dajti E, Frazzoni L, Iascone V, et al. Systematic review with meta-analysis: diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults. Aliment Pharmacol Ther. 2023;58(11-12):1120-1131. doi:10.1111/apt.17720
This article is intended for informational and educational purposes only. It does not constitute medical advice and should not be used as a substitute for professional medical guidance, diagnosis, or treatment.